Replication of Overall Survival, Progression-Free Survival, and Overall Response in Chemotherapy Arms of Non–Small Cell Lung Cancer Trials Using Real-World Data

PURPOSE: The utility of real-world data (RWD) for use as external controls in drug development is informed by studies that replicate trial control arms for different endpoints. The purpose of this study was to replicate control arms from four non–small cell lung cancer (NSCLC) randomized controlled...

Descripción completa

Detalles Bibliográficos
Autores principales: Ton, Thanh G.N., Pal, Navdeep, Trinh, Huong, Mahrus, Sami, Bretscher, Michael T., Machado, Robson J.M., Sadetsky, Natalia, Chaudhary, Nayan, Lu, Michael W., Riely, Gregory J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Association for Cancer Research 2022
Materias:
Clinical Trials: Immunotherapy
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9355621/
https://www.ncbi.nlm.nih.gov/pubmed/35511917
http://dx.doi.org/10.1158/1078-0432.CCR-22-0471

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9355621/
https://www.ncbi.nlm.nih.gov/pubmed/35511917
http://dx.doi.org/10.1158/1078-0432.CCR-22-0471

Ejemplares similares